GlassScriptPhysician profile
Daniel K Holleran
NPI 1225056468
$594.43
in general payments reported to CMS, 2019-2025
6 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.97 · 2020: $53.03 · 2021: $24.79 · 2022: $73.15 · 2023: $110 · 2024: $101 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $392.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $404.43 | 2019-2025 | Vanflyta, Injectafer |
| Janssen Biotech, INC. | $91.69 | 2023-2025 | Erleada, Carvykti |
| Merck Sharp & Dohme LLC | $34.21 | 2024-2025 | Keytruda, Welireg |
| Novartis Pharmaceuticals Corporation | $29.14 | 2023 | |
| Glaxosmithkline, LLC. | $19.97 | 2025 | Ojjaara |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Holleran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.